Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Montreal Cognitive Assessment (MoCA) Test
研究概览
简要总结
Deficits in memory, executive function, and language are common cognitive sequelae of aneurysmal subarachnoid hemorrhage (aSAH). Previous study demonstrated that post-treatment antiplatelet therapy reduced risk for delayed cerebral ischemia caused by aSAH. However, the effect of antiplatelet therapy on cognition after aSAH is unclear. The aim of this study was to assess the effect of antiplatelet therapy on cognition after aSAH.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with SAH in whom the aneurysm was proven by conventional angiography;
- •Baseline Hunt-Hess grade I-III;
- •patients received endovascular treatment
排除标准
- •Hunt-Hess grade IV-V;
- •Non-aneurysmal SAH;
- •Dementia in other diseases;
- •Lacking of 6-8 month MoCA evaluation.
研究组 & 干预措施
Antiplatelet-Y group
Patients with ruptured aneurysm underwent stent assisted coiling, with post-treatment antiplatelet therapy (aspirin and/or clopidogrel or ticagrelor)
干预措施: Antiplatelet Drug (Drug)
结局指标
主要结局
Montreal Cognitive Assessment (MoCA) Test
时间窗: 6-8 months
次要结局
未报告次要终点
研究者
Hai-Bin Shi
Professor
Nanjing Medical University
